Veren (NYSE:VRN) 주식

Veren

Veren Inc is an oil producer company. It is engaged in acquiring, developing, and holding interests in petroleum assets operations across western Canada.

D-Wave Quantum Inc.

Equities

Mid Cap

News

Movers

Trading Ideas

HSAI

IONQ

ORLA

PTGX

QBTS

RGTI

SMTC

이 중형주들은 지난주에 가장 좋은 성과를 냈습니다. 당신의 포트폴리오에 있나요? 1. D-웨이브 퀀텀(NYSE:QBTS)의 주식은 회사가 4분기 수주가 1억 8,300만 달러로 전년 대비 502% 증가했다고 보고한 후 95.95% 상승했다.

D-웨이브 퀀텀과 아이온큐 등 지난주 급등한 중형주 8종목 (3월 10일-3월 14일)

Veren Inc

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

VERANO HLDGS CORP by Verano Holdings Corp.

Verano Holdings Corp

Varonis Systems Inc

Verint Systems Inc

Scienture Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNX#NASDAQ">SCNX</a>) shares initially traded higher on Tuesday but have since reversed after the Food and Drug Administration (FDA) approved its <a href="https://www.benzinga.com//node/44374406">new drug application for Arbli.</a>
What To Know: Arbli (losartan potassium) is first and only FDA approved ready-to-use oral liquid losartan available in the United States.
It is designed to treat hypertension in patients over 6 years old, reduce stroke risk in patients with hypertension and left ventricular hypertrophy and treat diabetic nephropathy in certain patients with type 2 diabetes.
&#8220;We are pleased to bring to market, Arbli, a transformative therapy option containing losartan, one of the most widely prescribed molecules in its class, to patients, caregivers and healthcare professionals. We expect to commercially launch and make Arbli&nbsp;available to patients in the U.S. in&nbsp;Q3&nbsp;2025,&#8221; said Narasimhan Mani, President of Scienture.
See Also: <a href="https://www.benzinga.com/25/03/44378672/defense-stocks-are-soaring-expert-sees-170-as-achievable-by-year-end-for-this-preferred-pick">EXCLUSIVE: This Defense Stock Could Hit $170 &#8216;Before Year-End,&#8217; Expert Explains Why</a>
SCNX Price Action: At the time of writing, Scienture stock is trading 16.5% lower at $2.07, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

SCNX

What's Going On With Scienture Shares Tuesday?

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) saw its shares rise on Tuesday following the<a target="_blank" href="https://www.benzinga.com/news/earnings/25/03/44329381/this-week-in-cannabis-earnings-europes-buzzing-scene-the-un-and-more" rel="noreferrer noopener"> announcement of a product expansion</a>.
Manitoba Harvest, a leading hemp food company under Tilray, has launched its new Superseed Snack Clusters, which are available at <a href="https://www.benzinga.com//node/44372978">select Whole Foods Market stores nationwide.</a>
These snacks are crafted with a blend of premium seeds, including hemp hearts, pumpkin seeds, sunflower seeds, chia, and flax, offering a delicious and nutritious option for health-conscious consumers.
Each serving of Manitoba Harvest&#8217;s Superseed Snack Clusters provides 5 grams of plant-based protein, essential fatty acids, fiber, and a range of essential vitamins and minerals.
Available in three flavors – Maple Cinnamon, Dark Chocolate, and Smoky BBQ – these clusters aim to meet the growing demand for functional, guilt-free snacks.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44378155/exclusive-trumps-200-tariff-threat-could-price-european-alcohol-out-of-us-markets" rel="noreferrer noopener">EXCLUSIVE: Trump&#8217;s 200% Tariff Threat Could Price European Alcohol Out Of US Markets</a>
In addition to the snack launch, Tilray recently revealed an expansion for its <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/03/44283925/whats-going-on-with-cannabis-firm-tilray-brands-stock-on-wednesday" rel="noreferrer noopener">non-alcoholic craft beer brand, Runner&#8217;s High Brewing</a>.
The brand will now be available at 4,500 new distribution points, including major retailers like Publix, HEB, Harris Teeter, and Lowes Foods.
The move aims to make Runner&#8217;s High a go-to beverage for health-conscious consumers and beer lovers, offering varieties like Golden Wheat, Raspberry Wheat, and Dark Chocolate.
Tilray&#8217;s strategic moves to diversify its product portfolio reflect its commitment to wellness-focused offerings that cater to a growing market of health-minded individuals.
Price Action: TLRY shares are trading higher by 4.26% to $0.6720 at last check Tuesday.
Read also:
<ul>
<li><a href="https://www.benzinga.com/25/03/44376760/the-mag-7-slowdown-a-more-durable-transition-or-just-another-blip" target="_blank" rel="noreferrer noopener">EXCLUSIVE: The Mag 7 Slowdown – A &#8216;More Durable Transition&#8217; Or Just Another Blip?</a></li>
</ul>
Image Source: Tilray Brands, Inc.

Markets

General

TLRY

Tilray's Manitoba Harvest Rolls Out Superseed Snacks At Whole Foods

A Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analyst is significantly lowering the price target on the stock with concerns on full self-driving pricing and vehicle demand.
The analyst note comes with continued reports of low sales and used vehicle prices.
The Tesla Analyst: RBC Capital analyst Tom Narayan maintained an Outperform rating on Tesla while lowering the price target from $440 to $320.
"Much of the attention around Tesla has centered on its recent delivery performance in Jan and Feb in Europe and China," Narayan said.
Demand fears are likely overblown, according to Narayan. Europe and China, where Tesla is losing market share, represent a small portion of Tesla's overall vehicle sales, he adds.
Along with the potential for demand concerns, the analyst lowers FSD pricing assumptions and robotaxi penetration rates.
Narayan said FSD pricing could drop from $100/month today to $50/month in 2026.
"Level 2+ autonomy offerings are increasingly becoming standard features with some OEMs intentionally not seeking to make it a profit center, but rather as a product differentiator."
Tesla could also see lower than previously anticipated market share for robotaxis in Europe and China. It&#8217;s likely that domestic OEMs "dominate the market,&#8221; he says.
The latest price and market share changes lead to a lower sum-of-the-parts valuation with FSD going from $383 billion to $211 billion and robotaxis going from $879 billion to $641 billion.
Narayan also forecasts lower deliveries with an estimate of 11% delivery growth in fiscal 2025, down from an original forecast of 14% delivery growth.
Why It's Important: The big question from Narayan and other analysts is whether the lower delivery numbers are due to "political dynamics,&#8221; or have to do with the planned factory shutdowns for the Model Y refresh. Perhaps it&#8217;s a combination of both.
Electrek recently highlighted the sharp decline in used car prices for Tesla vehicles. The report said Tesla used car prices are falling three times the rate of the overall used car market.
Using data from CarGurus, the report said Tesla used prices are down 3.7% over the last three months and down 7.3% over the last year, compared to drops of 1.1% and 2.7% respectively for the overall used car market.
Among Tesla vehicles, the used car prices for the Cybertruck and Model S have been hit hardest falling 11.5% and 8.3% respectively over the last three months.
Benzinga recently polled readers to see if President Donald Trump&#8216;s purchase and praise for Tesla would impact their future vehicle-buying activity.
&#8220;Donald Trump recently bought a Tesla. How does this affect your view of Tesla?&#8221; Benzinga asked.
Here are the results:
<ul>
<li>I will never own a Tesla: 53%</li>
<li>I&#8217;m more likely to buy a Tesla:&nbsp;23%</li>
<li>I&#8217;m less likely to buy a Tesla: 14%</li>
<li>I already own a Tesla: 10%</li>
</ul>
The poll may have some bad news for Tesla fans and investors with the majority saying they will never own a Tesla vehicle.
The good news is that of undecided non-Tesla owners, 23% said they are more likely to buy a Tesla while 14% said they are less likely to buy a Tesla on account of Trump&#8217;s purchase and sales pitch for the EV company.
Tesla&#8217;s sales have dropped sharply in recent weeks, accompanied by demonstrations and vandalization against the company&#8217;s&nbsp;<a href="https://www.benzinga.com/25/03/44135841/elon-musk-slams-attacks-on-tesla-vehicles-after-incident-in-brookline-vandalism-is-not-free-speech" target="_blank" rel="noreferrer noopener">vehicles</a>, dealerships and charging hubs, according to&nbsp;<a href="https://abcnews.go.com/US/tesla-vehicles-destroyed-vandalized-musk-began-role-white/story?id=119677836" target="_blank" rel="noreferrer noopener">ABC News</a>. Declining sales are evident not just in the U.S., but also&nbsp;<a href="https://www.benzinga.com/news/25/03/44209579/unprecedented-slide-tesla-sales-plummet-45-in-europe-as-musks-net-worth-dives-5-2b-in-a-week" target="_blank" rel="noreferrer noopener">throughout Europe</a>,&nbsp;<a href="https://www.benzinga.com/tech/25/03/44069703/tesla-china-wholesale-numbers-are-unimportant-says-researcher-heres-what-matters-more" target="_blank" rel="noreferrer noopener">China</a>, and Australia.
A recent report from Electrek citing inventory checks and new order delivery timelines in the U.S. shows that so far Trump&#8217;s purchase and event has had&nbsp;<a href="https://www.benzinga.com/markets/25/03/44346155/trumps-tesla-shoutout-falls-flat-no-spike-in-orders-or-inventory-movement" target="_blank" rel="noreferrer noopener">a minimal impact&nbsp;</a>on Tesla&#8217;s sales and demand.
Tesla&#8217;s first-quarter sales figures, which will include the month of March will be among the most watched in recent years given boycotts, sales declines in Europe and now Trump&#8217;s sales pitch.
TSLA Price Action:&nbsp;Tesla stock is down 6% to $223.76 on Tuesday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is down 41.0% year-to-date in 2025 and up 28.8% over the last year.
Tesla stock is now trading below where it was when Trump won the 2024 election. Tesla stock closed at $251.44 on Nov. 5 and opened for trading at $284.67 on Nov. 6 after&nbsp;<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election" target="_blank" rel="noreferrer noopener">Trump&#8217;s victory was confirmed</a>.
The stock is down over 50% from all-time highs set in December.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/25/03/44339973/trump-said-nobody-wants-to-buy-evs-2-years-ago-now-hes-endorsing-and-says-hes-buying-a-tesla-heres-what-else-hes-been-saying-about-evs">Trump Said &#8216;Nobody Wants To Buy&#8217; EVs 2 Years Ago—Now He&#8217;s Endorsing Tesla At The White House</a></li>
</ul>
Image: Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

TSLA

Tesla Analyst Says Demand Fears 'Overblown,' But Has Some Concerns As Used Car Prices Plummet

Morgan Stanley analyst Hamza Fodderwala maintains Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) with a Equal-Weight and lowers the price target from $20 to $16.

JAMF

Morgan Stanley Maintains Equal-Weight on Jamf Holding, Lowers Price Target to $16

WIIM

Shares of major Europe-related ETFs are trading higher after the German parliament passed debt reforms which is expected to lead to an increase in defence and infrastructure spending.

Morgan Stanley analyst Ronald Kamdem maintains Hudson Pacific Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPP#NYSE">HPP</a>) with a Underweight and lowers the price target from $2.4 to $2.25.

Morgan Stanley Maintains Underweight on Hudson Pacific Properties, Lowers Price Target to $2.25

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) bull cycle appears to have <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44377385/bitcoin-remains-stuck-in-the-low-80000s-what-does-technical-analysis-say">come to an end</a>, according to Ki Young Ju, Founder and CEO of blockchain analytics firm CryptoQuant.
The comments follow fresh signals from CryptoQuant's proprietary PnL Index chart, which now reflects a sell signal that has historically aligned with prior market tops.
What Happened: "We are likely past the bull cycle peak," Ju <a href="https://x.com/ki_young_ju/status/1901776141024989658">said</a>, suggesting Bitcoin may face a prolonged period of sideways or bearish movement over the next six to twelve months.
The chart, spanning over a decade, plots Bitcoin's price alongside cyclical buy and sell signals derived from on-chain profitability metrics. 
The latest signal indicates a similar pattern to those seen in 2013, 2017, and 2021, each of which preceded either steep corrections or extended consolidation phases.
Bitcoin currently trades around $81,550, holding above key psychological levels despite broader market caution. 
This resilience is echoed by Nexo Dispatch analyst Iliya Kalchev, who described the market as entering a crucial consolidation phase. 
"Bitcoin is at a critical juncture," Kalchev said. "Support is holding around $82,000, but deeper levels near $73,000 may come into play depending on market sentiment."
While recent inflows to U.S. spot Bitcoin ETFs suggest some institutional confidence—<a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44377037/bitcoin-meanders-around-82500-as-etfs-net-275-million-in-inflows">with $274 million in net inflows recorded on Monda</a>y—the broader sentiment remains mixed amid macroeconomic uncertainty.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44374846/presearch-bolsters-web3-transition-with-pre-token-beta-launch-on-base-layer-2">Presearch Bolsters Web3 Transition With PRE Token Beta Launch On Base Layer 2</a>
"The renewed ETF interest could be a positive driver, but this market could still go in many directions," Kalchev added.
CryptoQuant's cyclical analysis reinforces these concerns, showing that Bitcoin tends to experience cooling-off periods following major cyclical tops. 
The historical chart's orange sell indicators, including the latest signal for 2025, have often been followed by six to twelve months of weak or sideways performance before new buying opportunities emerge.
The wider market is also reflecting caution. 
Kalchev noted Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) is hovering near $1,890, while Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) slipped to around $124 amid broader weakness in altcoins.
What&#8217;s Next: Amid these technical factors, the market's next moves could hinge on Wednesday's U.S. Federal Reserve rate decision, which may influence risk asset sentiment globally.
<a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44379524/what-will-happen-to-bitcoin-prices-if-donald-trump-and-vladimir-putin-agree-on-a-ceasefire-in-ukraine">Geopolitical uncertainties</a> and inflationary risks tied to U.S. tariffs have cast a shadow over investor confidence.
"This is a market in wait mode. Vigilance is key as institutional players weigh both the macro backdrop and on-chain signals,&#8221; Kalchev said.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44374550/bernstein-targets-310-for-coinbase-stock-cites-lifting-regulatory-dark-cloud">Bernstein Targets $310 For Coinbase Stock, Cites Lifting &#8216;Regulatory Dark Cloud&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$SOL

Bitcoin Is 'Past The Bull Cycle Peak,' Top Analyst Warns

The U.S. retail market had a bit of a rollercoaster start to 2025. February <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44355195/retail-sales-rebound-less-than-expected-in-february-online-healthcare-spending-show-strong-gains">retail sales</a> <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44355195/retail-sales-rebound-less-than-expected-in-february-online-healthcare-spending-show-strong-gains">edged up a modest 0.2%</a>, but that came after a steep downward revision for January, which now clocks in at a 1.2% decline. Economists were looking for a more robust bounce-back of about 0.6%, but consumer spending couldn&#8217;t quite match it.
For investors, this is a key question: what does this imply for <a href="https://www.benzinga.com/etfs">retail-oriented ETFs</a>? Because these ETFs follow the performance of retail stocks, they can take a hit from changes in consumer consumption. Let&#8217;s look at how recent retail data may affect these ETFs and what to expect next.
How Retail ETFs Are Reacting
Retail ETFs such as the SPDR S&amp;P Retail ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XRT#NYSE">XRT</a>) and VanEck Retail ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTH#NASDAQ">RTH</a>) provide investors with broad exposure to the industry. When consumers are spending more, these ETFs perform well. But when sales are weak, the effect can be uneven based on what is behind the numbers. In the past month, XRT has dipped as much as 13.93% and RTH, 7.42%.
February&#8217;s softer-than-expected growth might cause some short-term volatility, but not every sector of retail is suffering. Online shopping and health-related retail strength might see some ETFs perform better than others.
Also Read: <a href="https://www.benzinga.com/personal-finance/25/03/44360075/retail-giant-target-which-relies-on-china-for-30-of-its-merchandise-warns-of-profit-hit-as-trumps-trade-war-bites">Retail Giant Target, Which Relies On China For 30% Of Its Merchandise, Warns Of Profit Hit As Trump&#8217;s Trade War Bites</a>
Here&#8217;s a closer examination:
XRT, an equal-weighted fund, might come under some pressure because it distributes investments among a broad spectrum of retailers, some of which are suffering.
RTH, which relies more heavily on the likes of Amazon and Walmart, might fare better with the continued e-commerce strength.
Vanguard Consumer Discretionary Index Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VCR#NYSE">VCR</a>), which is exposed to brick-and-mortar as well as online stores, may have mixed results based on how various retail categories perform.
Dissecting The Retail Sales Figures
Based on the most recent U.S. Census Bureau report, here&#8217;s how retail sales held up:
<ul>
<li>February sales increased 0.2%—a modest increase but not the recovery economists were looking for.</li>
<li>January sales were revised to a 1.2% decline, emphasizing a softer beginning to the year.</li>
<li>Year-over-year, retail sales increased 3.1%, decelerating from the prior 3.9%.</li>
</ul>
Not all categories fared poorly, however. Online stores experienced a 2.4% increase in sales, demonstrating ongoing demand for e-commerce.
Health and personal care stores reported a 1.7% increase.
Excluding auto sales and gasoline stations, retail sales actually increased 0.5%, higher than the expected 0.4%.
The control group measure, which removes more erratic sectors, increased 1%, a robust bounce back from January&#8217;s 1% fall.
A number of factors probably held down consumer spending. 
<ul>
<li>Inflation is continuing to nibble at purchasing power, so shoppers are being more careful. </li>
<li>Increased interest rates might be deterring major purchases.</li>
<li>January&#8217;s weakness might have lingered, as shoppers pulled back after the holidays. </li>
<li>Changing consumer spending, with greater emphasis on necessities over discretionary goods.</li>
</ul>
While the disappointing top-line number is concerning, there are some silver linings in sight. The fact that online sales were strong indicates that e-commerce retailers continue to draw shoppers. That&#8217;s a plus for ETFs that have heavy exposure to e-commerce stocks.
What&#8217;s Next For Retail ETFs?
While retail sales missed the mark, sector-specific strength—particularly in e-commerce—may cushion the blow for some ETFs. Investors will want to watch inflation, interest rates, and overall consumer sentiment in the months ahead.
For those who want to ride out possible volatility, diversification within the retail space may be the way to go. Although broad retail ETFs may face some stress, those funds that have greater exposure to well-performing sub-sectors such as e-retail and medical products could be in better shape in the near term.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44363430/covered-call-etfs-a-smart-income-play-in-volatile-markets">Covered Call ETFs: A Smart Income Play In Volatile Markets</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

ETFs

Merrill Lynch Retail HOLDRS Trust due 12/31/41

Consumer Spending Stumbles: Time To Buy The Dip In Retail ETFs?

HYPR

Hyperfine shares are trading lower after the company reported worse-than-expected Q4 sales results.

HC Wainwright &amp; Co. analyst Ed Arce reiterates Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) from Neutral to Neutral.

PLRX

HC Wainwright & Co. Reiterates Neutral on Pliant Therapeuticsto Neutral

Morgan Stanley analyst Tejas Savant maintains GRAIL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>) with a Equal-Weight and raises the price target from $16 to $20.

GRAL

Morgan Stanley Maintains Equal-Weight on GRAIL, Raises Price Target to $20

Snow Lake Resources Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>), operating as Snow Lake Energy, shares are trading higher by 26.6% to 52 cents during Tuesday&#8217;s session. The company <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=319015644&amp;type=PDF&amp;symbol=LITM&amp;cdn=c1c6fa58c9f03cba8fb46f043c6f5d98&amp;companyName=Snow+Lake+Resources+Ltd.&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2025-03-18">announced</a> a $10 million share repurchase program.
What To Know: Snow Lake Resources says the company's board believes its stock may be undervalued and sees the buyback as a strategic use of corporate funds to enhance liquidity.
Initially, Snow Lake plans to repurchase up to 4,926,476 common shares through ThinkEquity LLC via Nasdaq, using open market purchases, private transactions, or other legal methods. But, the actual number of shares bought will depend on market conditions and regulatory constraints
The program begins on March 24, and runs for a month, ending either on April 24 or once the buyback limit is reached. Snow Lake retains the right to adjust or terminate the program at its discretion based on liquidity, market conditions, and corporate needs.
Read Also: <a href="https://www.benzinga.com/25/03/44376846/bigbearai-stock-is-trading-lower-today-whats-happening">BigBear.ai Stock Is Trading Lower Today: What&#8217;s Happening?</a>
<h2 class="wp-block-heading">How To Buy LITM Stock</h2>
By now you're likely curious about how to participate in the market for Snow Lake Resources &#8211; be it to purchase shares or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, LITM has a 52-week high of $1.88 and a 52-week low of $0.15.

LITM

Why Snow Lake Resources (LITM) Stock Is Up 26% Today

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) with a Buy and maintains $12 price target.

FEMY

HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $12 Price Target

Morgan Stanley analyst Hamza Fodderwala maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Overweight and raises the price target from $113 to $123.

FTNT

Morgan Stanley Maintains Overweight on Fortinet, Raises Price Target to $123

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) with a Buy and maintains $22 price target.

STOK

Needham Reiterates Buy on Stoke Therapeutics, Maintains $22 Price Target

Morgan Stanley analyst Hamza Fodderwala maintains Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Equal-Weight and raises the price target from $200 to $235.

CHKP

Morgan Stanley Maintains Equal-Weight on Check Point Software, Raises Price Target to $235

Alaska Air Group shares are trading lower. Citigroup cut its price target on the stock from $83 to $81.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTX#NASDAQ">ENTX</a>) with a Buy and maintains $10 price target.

ENTX

HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target

MLTX

MoonLake Immunotherapeutics shares are trading higher after RBC Capital initiated coverage on the stock with an Outperform rating and announced a price target of $67.

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) has outperformed the market over the past 5 years by 1.09% on an annualized basis producing an average annual return of 21.31%. Currently, GEO Group has a market capitalization of $3.70 billion. 
Buying $1000 In GEO: If an investor had bought $1000 of GEO stock 5 years ago, it would be worth $2,260.91 today based on a price of $26.43 for GEO at the time of writing.
<h3>GEO Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742312763_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Veren

뉴스

파트너 / 기고자

벤징가 글로벌